Barton Laws M, Bradshaw YS, Safren SA, Beach MC, Lee Y, Rogers W, Wilson IB. Discussion of sexual risk behavior in HIV care is infrequent and appears ineffectual: A mixed methods study. AIDS Behav. 2011 May;15(4):812-22.
Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, Wallace B, Hersh CP, Bagade S, Bertram L, Silverman EK, Trikalinos TA. The COPD genetic association compendium: A comprehensive online database of COPD genetic associations. Hum Mol Genet. 2010 Feb 1;19(3):526-34.
Castaldi PJ, DeMeo DL, Kent DM, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Stocks JM, Stoller JK, Strange C, Turino G, Sandhaus RA, Griffith JL, Silverman EK. Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am J Epidemiol. 2009 Oct 15;170(8):1005-13.
Castaldi PJ, Rogers WH, Safran DG, Wilson IB. Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease. Chest. 2010 Sep;138(3):614-20.
Ceglia L, Chiu GR, Harris SS, Araujo AB. Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clin Endocrinol (Oxf). 2011 Mar;74(3):370-6.
Ceglia L, da Silva Morais M, Park LK, Morris E, Harris SS, Bischoff-Ferrari HA, Fielding RA, Dawson-Hughes B. Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol. 2010 Apr;41(2-3):137-42.
Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Kelleher C, Schrier RW. The HALT polycystic kidney disease trials: Design and implementation. Clin J Am Soc Nephrol. 2010 Jan;5(1):102-9.
Concannon TW, Kent DM, Normand SL, Newhouse JP, Griffith JL, Cohen J, Beshansky JR, Wong JB, Aversano T, Selker HP. Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):506-13.
Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011 Feb 23;305(8):822-3.
Dahabreh IJ, Kitsios GD, Kent DM, Trikalinos TA. Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet Med. 2010 Oct;12(10):606-15.
Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: Systematic review and meta-analysis. JAMA. 2011 Mar 23;305(12):1225-33.
Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destee A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Kruger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilarino-Guell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ, Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Independent and joint effects of the MAPT and SNCA genes in parkinson disease. Ann Neurol. 2011 May;69(5):778-92.
Gabbay E, Calvo-Broce J, Meyer KB, Trikalinos TA, Cohen J, Kent DM. The empirical basis for determinations of medical futility. J Gen Intern Med. 2010 Oct;25(10):1083-9.
Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: Genetic heterogeneity and individual predisposition to cancer. Trends Genet. 2010 Mar;26(3):132-41.
Greenblatt DJ, Peters DE, Oleson LE, Harmatz JS, MacNab MW, Berkowitz N, Zinny MA, Court MH. Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase. Br J Clin Pharmacol. 2009 Dec;68(6):920-7.
Ioannidis JP, Castaldi P, Evangelou E. A compendium of genome-wide associations for cancer: Critical synopsis and reappraisal. J Natl Cancer Inst. 2010 Jun 16;102(12):846-58.
Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet. 2009 May;10(5):318-29.
Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic RIsk prediction studies: The GRIPS statement. PLoS Med. 2011 Mar;8(3):e1000420.
Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: The GRIPS statement. BMJ. 2011 Mar 16;342:d631.
Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: The GRIPS statement. Circ Cardiovasc Genet. 2011 Apr;4(2):206-9.
Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: The GRIPS statement. Ann Intern Med. 2011 Mar 15;154(6):421-5.
Johnson TA, Qiu J, Plaut AG, Holyoak T. Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease. J Mol Biol. 2009 Jun 12;389(3):559-74.
Kaitin KI. Deconstructing the drug development process: The new face of innovation. Clin Pharmacol Ther. 2010 Mar;87(3):356-61.
Kawut SM, Bagiella E, Shimbo D, Lederer DJ, Al-Naamani N, Roberts KE, Barr RG, Post W, Horn EM, Tracy R, Hassoun P, Girgis R, ASA-STAT Study Group. Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. Contemp Clin Trials. 2011 Mar;32(2):280-7.
Kent DM, Kitsios G. Against pragmatism: On efficacy, effectiveness and the real world. Trials. 2009 Jul 6;10:48.
Kent DM, Lindenauer PK. Aggregating and disaggregating patients in clinical trials and their subgroup analyses. Ann Intern Med. 2010 Jul 6;153(1):51-2.
Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009 Nov 25;302(20):2254-6.
Kent DM, Trikalinos TA, Hill MD. Are unadjusted analyses of clinical trials inappropriately biased toward the null? Stroke. 2009 Mar;40(3):672-3.
Kerkhof HJ, Lories RJ, Meulenbelt I, Jonsdottir I, Valdes AM, Arp P, Ingvarsson T, Jhamai M, Jonsson H, Stolk L, Thorleifsson G, Zhai G, Zhang F, Zhu Y, van der Breggen R, Carr A, Doherty M, Doherty S, Felson DT, Gonzalez A, Halldorsson BV, Hart DJ, Hauksson VB, Hofman A, Ioannidis JP, Kloppenburg M, Lane NE, Loughlin J, Luyten FP, Nevitt MC, Parimi N, Pols HA, Rivadeneira F, Slagboom EP, Styrkarsdottir U, Tsezou A, van de Putte T, Zmuda J, Spector TD, Stefansson K, Uitterlinden AG, van Meurs JB. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum. 2010 Feb;62(2):499-510.
Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O'Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JP. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009 Aug 1;170(3):269-79.
Kitsios G, Zintzaras E. ACE (I/D) polymorphism and response to treatment in coronary artery disease: A comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet. 2009 Jun 4;10:50.
Kitsios GD, Dahabreh IJ, Trikalinos TA, Schmid CH, Huggins GS, Kent DM. Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Circ Cardiovasc Genet. 2011 Feb 1;4(1):58-67.
Kitsios GD, Stefanidis I, Zintzaras E. Lack of association between common endothelial nitric oxide synthase gene haplotypes and left ventricular hypertrophy in hypertension. DNA Cell Biol. 2010 Jun;29(6):273-6.
Kitsios GD, Tangri N, Castaldi PJ, Ioannidis JP. Laboratory mouse models for the human genome-wide associations. PLoS One. 2010 Nov 1;5(11):e13782.
Kitsios GD, Zintzaras E. Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: The CUMAGAS-HYPERT database. Am J Hypertens. 2010 Mar;23(3):305-13.
Kitsios GD, Zintzaras E. Genome-wide association studies: Hypothesis-"free" or "engaged"? Transl Res. 2009 Oct;154(4):161-4.
Kitsios GD, Zintzaras E. Genomic convergence of genome-wide investigations for complex traits. Ann Hum Genet. 2009 Sep;73(Pt 5):514-9.
Kraft P, Zeggini E, Ioannidis JP. Replication in genome-wide association studies. Stat Sci. 2009 Nov 1;24(4):561-73.
Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: A meta-analytic approach. J Am Coll Cardiol. 2010 Jul 27;56(5):392-406.
Kroenke K, Kapoor W, Helfand M, Meltzer DO, McDonald MA, Selker H. Training and career development for comparative effectiveness research workforce development: CTSA consortium strategic goal committee on comparative effectiveness research workgroup on workforce development. Clin Transl Sci. 2010 Oct;3(5):258-62.
Lubin AS, Snydman DR, Ruthazer R, Bide P, Golan Y. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus bloodstream infections. Clin Infect Dis. 2011 Apr 15;52(8):997-1002.
Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis. 2011 Feb;214(2):468-73.
Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol. 2011 Jan;6(1):7-13.
Milne CP, Kaitin KI. Impact of the new US health-care-reform legislation on the pharmaceutical industry: Who are the real winners? Clin Pharmacol Ther. 2010 Nov;88(5):589-92.
Padmapriyadarsini C, Ramesh Kumar S, Terrin N, Narendran G, Menon PA, Ramachandran G, Subramanyan S, Venkatesan P, Wanke C, Swaminathan S. Dyslipidemia among HIV-infected patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in india. Clin Infect Dis. 2011 Feb 15;52(4):540-6.
Pereira TV, Patsopoulos NA, Salanti G, Ioannidis JP. Discovery properties of genome-wide association signals from cumulatively combined data sets. Am J Epidemiol. 2009 Nov 15;170(10):1197-206.
Pfeiffer T, Bertram L, Ioannidis JP. Quantifying selective reporting and the proteus phenomenon for multiple datasets with similar bias. PLoS One. 2011 Mar 29;6(3):e18362.
Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009 Mar;94(3):827-32.
Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant. 2011 Feb;46(2):300-7.
Rhee MS, Schmid CH, Stevens LA, Forrester JE. Risk factors for proteinuria in HIV-infected and -uninfected hispanic drug users. Am J Kidney Dis. 2008 Oct;52(4):683-90.
Salanti G, Southam L, Altshuler D, Ardlie K, Barroso I, Boehnke M, Cornelis MC, Frayling TM, Grallert H, Grarup N, Groop L, Hansen T, Hattersley AT, Hu FB, Hveem K, Illig T, Kuusisto J, Laakso M, Langenberg C, Lyssenko V, McCarthy MI, Morris A, Morris AD, Palmer CN, Payne F, Platou CG, Scott LJ, Voight BF, Wareham NJ, Zeggini E, Ioannidis JP. Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol. 2009 Sep 1;170(5):537-45.
Selker HP. Clinical research and the public: If not them, who? Clin Transl Sci. 2010 Aug;3(4):132-3.
Selker HP, Leslie LK, Wasser JS, Plaut AG, Wilson IB, Griffith JL. Tufts CTSI: Comparative effectiveness research as a conceptual framework for a focus on impact. Clin Transl Sci. 2010 Apr;3(2):56-8.
Selker HP, Ruthazer R, Terrin N, Griffith JL, Concannon T, Kent DM. Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci. 2011 Feb;4(1):10-6.
Selker HP, Strom BL, Ford DE, Meltzer DO, Pauker SG, Pincus HA, Rich EC, Tompkins C, Whitlock EP. White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci. 2010 Feb;3(1):29-37.
Singh R, Visintainer PF, Frantz ID,3rd, Shah BL, Meyer KM, Favila SA, Thomas MS, Kent DM. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol. 2011 Mar;31(3):176-82.
Starmer AJ, Duby JC, Slaw KM, Edwards A, Leslie LK, Members of Vision of Pediatrics 2020 Task Force. Pediatrics in the year 2020 and beyond: Preparing for plausible futures. Pediatrics. 2010 Nov;126(5):971-81.
Terasawa T, Dahabreh IJ, Nihashi T. Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: A systematic review and meta-analysis. Oncologist. 2010;15(7):750-9.
Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: A quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009 Mar 14;373(9667):911-8.
Wagner M, Balk EM, Kent DM, Kasiske BL, Ekberg H. Subgroup analyses in randomized controlled trials: The need for risk stratification in kidney transplantation. Am J Transplant. 2009 Oct;9(10):2217-22.
Wilson IB, Laws MB, Safren SA, Lee Y, Lu M, Coady W, Skolnik PR, Rogers WH. Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr. 2010 Mar 1;53(3):338-47.
Xu K, Rajagopal S, Klebba I, Dong S, Ji Y, Liu J, Kuperwasser C, Garlick JA, Naber SP, Buchsbaum RJ. The role of fibroblast Tiam1 in tumor cell invasion and metastasis. Oncogene. 2010 Dec 16;29(50):6533-42.
Zucker DR, Deo A, Schmid CH. Dialysis research and N-of-1 trials: Made for each other? Am J Kidney Dis. 2010 Apr;55(4):635-8.
Zuckerman R, Getz K, Kaitin K. A new mechanism for tracking publicly available study volunteer demographics. Drug Inf J. 2011 Jan 1;45(1):55-64.
